Cite
Optimized New Shengmai Powder modulation of cAMP/Rap1A signaling pathway attenuates myocardial fibrosis in heart failure
MLA
Zeyu Zhang, et al. “Optimized New Shengmai Powder Modulation of CAMP/Rap1A Signaling Pathway Attenuates Myocardial Fibrosis in Heart Failure.” Chinese Medicine, vol. 19, no. 1, Feb. 2024, pp. 1–20. EBSCOhost, https://doi.org/10.1186/s13020-024-00902-4.
APA
Zeyu Zhang, Zhe xu, Shuai Wang, Zhuangzhuang Jia, Zhou zhou, Ci Wang, Shanshan Lin, Yiting Feng, Xianliang Wang, & Jingyuan Mao. (2024). Optimized New Shengmai Powder modulation of cAMP/Rap1A signaling pathway attenuates myocardial fibrosis in heart failure. Chinese Medicine, 19(1), 1–20. https://doi.org/10.1186/s13020-024-00902-4
Chicago
Zeyu Zhang, Zhe xu, Shuai Wang, Zhuangzhuang Jia, Zhou zhou, Ci Wang, Shanshan Lin, Yiting Feng, Xianliang Wang, and Jingyuan Mao. 2024. “Optimized New Shengmai Powder Modulation of CAMP/Rap1A Signaling Pathway Attenuates Myocardial Fibrosis in Heart Failure.” Chinese Medicine 19 (1): 1–20. doi:10.1186/s13020-024-00902-4.